SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Oppenheimer Maintains Outperform on Baudax Bio, Lowers Price Target to $14

Oppenheimer maintains Baudax Bio (NASDAQ:BXRX) with a Outperform and lowers the price target from $16 to $14.

Benzinga · 05/11/2020 11:40

Oppenheimer maintains Baudax Bio (NASDAQ:BXRX) with a Outperform and lowers the price target from $16 to $14.